Disulfide-Bridged Chitosan-Eudragit S-100 Nanoparticles for Colorectal Cancer
- 3 October 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 2 (10) , 6409-6417
Abstract
No abstract availableKeywords
Funding Information
- Anusandhan National Research Foundation (YSS/2015/001706, ECR/2016/000633/LS)
- Nano Mission Council, Department of Science and Technology (SR/NM/NB-1108/2016)
- Department of Biotechnology , Ministry of Science and Technology (BT/PR27008/NNT/28/1525/-2017, 102/IFD/SAN/1734/2016-2017)
This publication has 36 references indexed in Scilit:
- Role of Glutathione in Cancer Progression and ChemoresistanceOxidative Medicine and Cellular Longevity, 2013
- Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriersAdvanced Drug Delivery Reviews, 2012
- Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin deliveryEuropean Journal of Pharmaceutical Sciences, 2011
- Synthesis and characterization of thiolated alginate-albumin nanoparticles stabilized by disulfide bonds. Evaluation as drug delivery systemsCarbohydrate Polymers, 2011
- Chitosan Modification and Pharmaceutical/Biomedical ApplicationsMarine Drugs, 2010
- An Investigation into the Digestion of Chitosan (Noncrosslinked and Crosslinked) by Human Colonic BacteriaJournal of Pharmaceutical Sciences, 2008
- Chitosan-modifications and applications: Opportunities galoreReactive and Functional Polymers, 2008
- Thiolated chitosans: useful excipients for oral drug deliveryJournal of Pharmacy and Pharmacology, 2008
- Glutathione in Cancer Biology and TherapyCritical Reviews in Clinical Laboratory Sciences, 2006
- Monodisperse Chitosan Nanoparticles for Mucosal Drug DeliveryBiomacromolecules, 2004